Introduction
iCAN is a groundbreaking Finnish Research Flagship dedicated to solving the cancer challenge through cutting-edge discovery and innovation. The flagship is at the interface of precision cancer medicine and digital health, with the aim of advancing research and providing innovative solutions to tackle cancer.
iCAN News
iCAN science seminar on Biology as a compass: multimodal profiling and treatment prediction in ovarian cancer with Dr. Francis Jacob
Dr. Francis Jacob from the University Hospital and University of Basel will give a talk “Biology as a compass: multimodal…
Prof. Satu Mustjoki awarded with Medix 2024 prize
iCAN’s Scientific Director, Professor Satu Mustjoki is awarded with Medix 2024 prize for the study published in the Immunity journal…
iCAN retreat 2024 brought together our community
On 3rd October 2024, the iCAN community gathered for the iCAN retreat, hosting around 250 participants onsite and online, including project researchers, board members,…
iCAN in Numbers
iCAN Study Participants
Company collaborations
iCAN Publications
Invention
Disclosures
Patents
External Funding